Table 2. Currently approved cytokines for oncological indications*.

Agent	Commercial names		Oncological indications
IFNα2b	Intron A, Roferon-A		Cervical intraepithelial neoplasia, CML, FL, HCL, melanoma, MM
IL-2	Aldesleukin, Proleukin		Metastatic melanoma, metastatic renal cell carcinoma

Abbreviations: CML, chronic myeloid leukemia; FL, follicular lymphoma, HCL, hairy cell leukemia, IFN, interferon; IL, interleukin; MM, multiple myeloma. *by FDA or European Medicines Agency (EMA) at the day of submission.